Literature DB >> 12216081

Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?

Volker M Arlt, Dusan Ferluga, Marie Stiborova, Annie Pfohl-Leszkowicz, Mato Vukelic, Stjepan Ceovic, Heinz H Schmeiser, Jean-Pierre Cosyns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12216081     DOI： 10.1002/ijc.10602

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  26 in total

1.  Differential methylation pattern of xenobiotic metabolizing genes and susceptibility to Balkan endemic nephropathy, in a cohort of Romanian patients.

Authors:  Alexandra Ivan; Dilys Lam; Mirabela Iustina Cristea; Ada Telea; Alexandra Teodora Gruia; Camelia Oprean; Florin Margineanu; Florina Maria Bojin; Richard Saffery; Virgil Paunescu; Calin Adrian Tatu
Journal:  J Nephrol       Date:  2019-06-20       Impact factor: 3.902

2.  Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy.

Authors:  Romina di Giuseppe; Terenzio Bertuzzi; Filippo Rossi; Silvia Rastelli; Annalisa Mulazzi; Jessica Capraro; Amalia de Curtis; Licia Iacoviello; Amedeo Pietri
Journal:  Eur J Nutr       Date:  2011-10-29       Impact factor: 5.614

3.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

Review 4.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

Review 5.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

Review 7.  Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.

Authors:  David T Long; Thomas C Voice
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

8.  Aristolochic acid and the etiology of endemic (Balkan) nephropathy.

Authors:  Arthur P Grollman; Shinya Shibutani; Masaaki Moriya; Frederick Miller; Lin Wu; Ute Moll; Naomi Suzuki; Andrea Fernandes; Thomas Rosenquist; Zvonimir Medverec; Krunoslav Jakovina; Branko Brdar; Neda Slade; Robert J Turesky; Angela K Goodenough; Robert Rieger; Mato Vukelić; Bojan Jelaković
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 9.  The involvement of mycotoxins in the development of endemic nephropathy.

Authors:  Maja Peraica; Ana-Marija Domijan; Marica Miletić-Medved; Radovan Fuchs
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  Preventing aristolochic acid nephropathy.

Authors:  Nelomi Anandagoda; Graham M Lord
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.